Emerging Company Profile
Spotlight: solving CRISPR’s delivery challenges with RNPs
Emerging Company Profile: Spotlight developing tissue-targeted CRISPR therapies with $30M A round led by GV
Spotlight emerged from stealth with a technology for tissue-targeted delivery of CRISPR therapies and a $30 million GV-led series A round.
Spotlight emerged from stealth on Monday with a $30 million series A round led by GV and a platform that could help address the challenge of systemically delivering CRISPR-based gene